GHRL and dementia: Mechanistically, we reasoned that as circulating levels of acyl-ghrelin and UAG have opposing actions on neurogenesis and cognition in mice and that UAG inhibits acyl-ghrelin-mediated cell proliferation and survival in vitro, this may be reflected in the plasma ratio of acyl-ghrelin to UAG (AG:UAG) in humans diagnosed with dementia.